Loading…
Catheter Precision, Inc.
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in VTAK.
▼ -100.0% over 5Y.
today you would have $0.01▼ -100.0%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 8 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $1.83 | $8.55 | $76.00 | $1,119.10 | $14,820.00 | $70,585.00 | $268,375.00 | $1,888,125.00 | |
| P/S | 8.4x | 6.0x | 9.9x | 6.9x | 2096.9x | 2230.4x | 5.5x | 2.2x | 16.0x |
| P/B | 0.9x | 0.7x | 0.4x | 0.1x | 3.2x |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| NIVFNewGenIvf Group Ltd | $0.34 | 0.0x | 0.0x | — | 79.40% | $833.53K |
| BDRXBiodexa Pharmaceuticals Plc | $0.87 | — | 0.0x | — | -64.72% | $893.33K |
| BJDXBluejay Diagnostics, Inc. | $0.90 | — | 0.2x | — | -98.89% | $931.24K |
| PFSAProfusa, Inc. | $1.69 |
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures; and LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures. Catheter Precision, Inc. was formerly known as Catheter Robotics Inc. The company is based in Fort Mill, South Carolina.
Company description provided by Yahoo Finance.
| 3.6x |
| 1.1x |
| 0.5x |
| 1.5x |
| EPS | -$15.90 | -$126.91 | -$2,467.72 | -$4,936.20 | -$47,161.80 | -$201,590.00 | -$1,028,660.00 | -$793,250.00 |
| Profit margin | -3030.33% | -2098.05% | -3962.62% | -15966.52% | -191892.86% | -113954.55% | -818.27% | -791.18% | -492.76% |
| ROE | -177.59% | -243.59% | -141.56% | -333.00% | -290.12% | -183.35% | -170.45% | -171.82% | -46.21% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| — |
| — |
| — |
| $1.02M |
| CDTCDT Equity Inc. | $1.69 | — | 0.0x | — | -69.68% | $1.33M |
| ARTLArtelo Biosciences Inc | $0.66 | — | 0.6x | — | -705.71% | $363.01K |